Arm (ARM)

The sleeper story is CSS royalty rate escalation within v9 - Haas revealed these rates increase annually, creating a compounding premium the market is missing. Record $983M revenue beats, but v9 adoption stalled at 25% for multiple quarters despite being the core growth driver, with management admitting surprise. The binding constraint is execution visibility - ACV growth decelerated to 9% and Q4 licensing guide depends on 'hundreds of millions' in deals that 'can be hard to forecast.' Most telling quote: Child acknowledging v9 stall is 'a little bit surprising to us' - when management loses visibility on their key metric, that's a red flag. My view changes if v9 penetration resumes 500bp quarterly increases or if Q4 licensing deals slip, proving the wide guidance range was justified.